UWMC vs. IOVA

Last updated Jun 4, 2026

UWMC (UWM Holdings Corporation) and IOVA (Iovance Biotherapeutics, Inc.) are both stocks. UWMC operates in Mortgage Finance (Financial Services), while IOVA operates in Biotechnology (Healthcare). Over the past 5 years, UWMC returned -14.78%/yr vs -26.71%/yr for IOVA. At a 0.29 correlation, their price movements are largely independent.

Performance

UWMC vs. IOVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UWM Holdings Corporation (UWMC) and Iovance Biotherapeutics, Inc. (IOVA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, UWMC achieves a -35.94% return, which is significantly lower than IOVA's 38.83% return.

UWMC

• 1D: -8.08%
• 1M: -22.88%
• YTD: -35.94%
• 6M: -49.47%
• 1Y: -27.57%
• 3Y*: -13.32%
• 5Y*: -14.78%
• 10Y*: —

IOVA

• 1D: -7.56%
• 1M: -1.56%
• YTD: 38.83%
• 6M: 71.49%
• 1Y: 108.24%
• 3Y*: -24.48%
• 5Y*: -26.71%
• 10Y*: -7.92%

*Multi-year figures are annualized to reflect compound growth (CAGR)

UWMC vs. IOVA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
UWMC UWM Holdings Corporation	-35.94%	-19.30%	-13.04%	132.11%	-38.03%	-28.60%
IOVA Iovance Biotherapeutics, Inc.	38.83%	-63.11%	-8.98%	27.23%	-66.53%	-39.91%

Correlation

The correlation between UWMC and IOVA is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.24
Correlation (3Y) Calculated over the trailing 3-year period	0.27
Correlation (5Y) Calculated over the trailing 5-year period	0.28
Correlation (All Time) Calculated using the full available price history since Mar 5, 2021	0.29

Fundamentals

Market Cap UWMC : $4.37B IOVA : $1.59B
EPS UWMC : $0.37 IOVA : -$0.93
PS Ratio UWMC : 0.50 IOVA : 5.06
PB Ratio UWMC : 2.73 IOVA : 2.20
Total Revenue (TTM) UWMC : $3.10B IOVA : $285.61M
Gross Profit (TTM) UWMC : $1.79B IOVA : $327.04M
EBITDA (TTM) UWMC : $1.03B IOVA : -$325.45M

Return for Risk

UWMC vs. IOVA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UWMC

UWMC Risk / Return Rank: 21
UWMC Sharpe Ratio Rank: 19
UWMC Sortino Ratio Rank: 20
UWMC Omega Ratio Rank: 21
UWMC Calmar Ratio Rank: 24
UWMC Martin Ratio Rank: 21

IOVA

IOVA Risk / Return Rank: 72
IOVA Sharpe Ratio Rank: 73
IOVA Sortino Ratio Rank: 77
IOVA Omega Ratio Rank: 72
IOVA Calmar Ratio Rank: 73
IOVA Martin Ratio Rank: 66

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UWMC vs. IOVA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for UWM Holdings Corporation (UWMC) and Iovance Biotherapeutics, Inc. (IOVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UWMC	IOVA	Difference
Sharpe ratio Return per unit of total volatility	-0.51	1.07	-1.58
Sortino ratio Return per unit of downside risk	-0.47	2.16	-2.63
Omega ratio Gain probability vs. loss probability	0.95	1.25	-0.30
Calmar ratio Return relative to maximum drawdown	-0.48	2.00	-2.48
Martin ratio Return relative to average drawdown	-0.99	3.14	-4.13
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UWMC vs. IOVA - Sharpe Ratio Comparison

The current UWMC Sharpe Ratio is -0.51, which is lower than the IOVA Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of UWMC and IOVA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	UWMC	IOVA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.51	1.07	-1.58
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.29	-0.30	+0.01
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.10	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.27	-0.13	-0.14

Drawdowns

UWMC vs. IOVA - Drawdown Comparison

The maximum UWMC drawdown since its inception was -68.67%, smaller than the maximum IOVA drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for UWMC and IOVA.

Drawdown Indicators

	UWMC	IOVA	Difference
Max Drawdown Largest peak-to-trough decline	-68.67%	-99.37%	+30.70%
Max Drawdown (1Y) Largest decline over 1 year	-57.91%	-54.41%	-3.50%
Max Drawdown (3Y) Largest decline over 3 years	-67.19%	-90.50%	+23.31%
Max Drawdown (5Y) Largest decline over 5 years	-68.67%	-93.99%	+25.32%
Max Drawdown (10Y) Largest decline over 10 years	—	-96.84%	—
Current Drawdown Current decline from peak	-67.19%	-97.62%	+30.43%
Average Drawdown Average peak-to-trough decline	-37.17%	-84.16%	+46.99%
Ulcer Index Depth and duration of drawdowns from previous peaks	27.87%	34.64%	-6.77%

Volatility

UWMC vs. IOVA - Volatility Comparison

The current volatility for UWM Holdings Corporation (UWMC) is 11.81%, while Iovance Biotherapeutics, Inc. (IOVA) has a volatility of 24.33%. This indicates that UWMC experiences smaller price fluctuations and is considered to be less risky than IOVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UWMC	IOVA	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.81%	24.33%	-12.52%
Volatility (6M) Calculated over the trailing 6-month period	39.51%	62.96%	-23.45%
Volatility (1Y) Calculated over the trailing 1-year period	54.13%	101.64%	-47.51%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	50.73%	89.79%	-39.06%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	50.72%	81.28%	-30.56%

Dividends

UWMC vs. IOVA - Dividend Comparison

UWMC's dividend yield for the trailing twelve months is around 14.65%, while IOVA has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021
IOVA Iovance Biotherapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
UWMC UWM Holdings Corporation	14.65%	9.13%	6.81%	5.59%	12.08%	6.76%

Financials

Frequently Asked Questions

Can I hold both UWMC and IOVA in my portfolio?

UWMC and IOVA have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, UWMC or IOVA?

IOVA has higher volatility (24.33%) compared to UWMC (11.81%). In terms of maximum drawdown, UWMC dropped -68.67% vs IOVA's -99.37%.

Which has better risk-adjusted returns?

IOVA currently has the higher Sharpe Ratio (1.07 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.